Outro Announces $7M in Funding to Expand Access to Safe Deprescribing, Starting With Antidepressants
The New Capital Will Accelerate Outro’s Mission to Close America’s Deprescribing Gap Across Medication Classes, and Advance Novel Research in Partnership with Leading Academic Institutions Outro, the first neuroscience-based platform helping Americans safely discontinue psychiatric medications, today announced $7 milli
